Fiche centre
University Health Network
Toronto — Canada
Essais liés4clinical trials
VilleTorontolocalisation
PaysCanadalocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT04606381
Essais cliniques associés
4| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Ami-LC-MD | Cancer | Phase 1 | NCT04606381 | PALOMA — A Study of Amivantamab Subcutaneous (SC) Administration for the Treatment of Advanced Solid Malignancies | ACTIVE_NOT_RECRUITING |
| Apalutamide 60mg Tab | Cancer | Phase 2 | NCT04812366 | GUNS — Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer | RECRUITING |
| Prasinezumab | Parkinson | Phase 3 | NCT07174310 | PARAISO — A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease | RECRUITING |
| The Ontario Neurodegenerative Disease Research Initiative | Sclérose latérale amyotrophique | À vérifier | NCT04104373 | The Ontario Neurodegenerative Disease Research Initiative | COMPLETED |